Feb. 24, 2022 — These days, when doctors prescribe a treatment for a patient who’s positive for COVID-19, their list of options is longer than ever. That’s the good news. But the abundance of options comes with many questions. Before deciding which of those treatments is best to keep you alive and perhaps even out … Read more
No fatalities were reported during the study, it added. Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine. The results, presented as an Oral Abstract at the Conference on Retroviruses and Opportunistic Infections (CROI) held virtually February 12–16, 2022, demonstrated that Molnupiravir along … Read more